Related Experiment Video

Updated: Sep 20, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Construction of an allosteric trans-maxizyme targeting for two distinct oncogenes

Mayu Iyo1, Hiroaki Kawasaki, Kazunari Taira

  • 1Department of Chemistry and Biotechnology, School of Engineering, University of Tokyo, 7-3-1 Hongo, Tokyo 113-8656, Japan.

Nucleic Acids Research. Supplement (2001)
|August 9, 2003
PubMed

Insights

Researchers designed a trans-maxizyme to target specific cancer genes, cyclinD1 and hst-1, in breast cancer cells. This approach aims for precise gene therapy, avoiding damage to healthy cells by cleaving target RNA only when both oncogenes are present.

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Cancer Research

Background:

  • Maxizymes are engineered ribozymes capable of cleaving specific RNA targets.
  • Overexpression of oncogenes cyclinD1 and hst-1 is linked to breast cancer development.
  • Conventional ribozymes may lack specificity, affecting both cancerous and normal cells.

Purpose of the Study:

  • To design a novel trans-maxizyme for targeted cancer gene therapy.
  • To achieve specific cleavage of cyclinD1 and hst-1 oncogene mRNAs in breast cancer cells.
  • To develop a therapeutic strategy that minimizes off-target effects on healthy cells.

Main Methods:

  • Design and engineering of a trans-maxizyme construct.
  • Utilizing the allosteric properties of maxizymes for target recognition.
  • Focusing on the oncogenes cyclinD1 and hst-1 overexpressed in breast cancer.

Main Results:

  • The trans-maxizyme demonstrates potential for allosteric RNA cleavage.
  • The designed maxizyme aims to specifically target oncogenic mRNAs in cancer cells.
  • This approach seeks to differentiate between cancerous and normal cellular targets.

Conclusions:

  • Trans-maxizymes offer a promising strategy for targeted cancer gene therapy.
  • The specificity of maxizymes can be harnessed to overcome limitations of conventional ribozymes.
  • This research paves the way for developing safer and more effective breast cancer treatments.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...